Important context for my portfolio reviews: I run a concentrated portfolio and WARNING the swings can be huge. From the 2021 high to the 2022 low, my portfolio fell more than 60%. For every $100 I had at the top I had just $40 left! Staggering. So, before trying this style, even with a small portion of your total net worth, please understand the downside – it’s much steeper than if you own an index, or a bunch of megacaps. Also, don’t follow or copy me, Saul, or anyone. We may sell a position or buy a new one at any time, so it’s impossible to follow anyway. Also, to succeed with a concentrated portfolio, you must rely on your own decisions.
The portfolio ended up getting completely overhauled this month. Okta, Nvidia, and Monday are new positions. More on those below.
I bought and sold Confluent during the month. I just couldn’t get over the revenue slow down plus FCF losses. I’ll keep an eye on them, but I just want to see some numbers moving in the right direction before I buy back in.
I also sold:
BILL - BILL Q4 results - #2 by PaulWBryant
Datadog - Growth has slowed a LOT. I just see this one going sideways for several quarters.
Crowdstrike and Zscaler - These might do ok, but I don’t see a ton of upside. I’d been reducing so I just decided to get out as a matter of portfolio streamlining.
Hashicorp - Growth is just slowing too fast.
A lot of these exits happened the last few days, leaving me with 44.9% cash. Cash actually got below 18% a couple weeks ago. My portfolio is up almost 10% since then…quite a run…so I think it’s a decent time to have a little cash. I would build up some of my smaller positions if the price was right. Or better yet, maybe something new will come along.
A word about the positions I own:
Axon - This one is growing better than most and the multiple is lower than most and profitability is increasing. What’s not to love?
Samsara - Our fastest growing SaaS company right now. It’s not cheap, but they sure do keep putting up the numbers. Profitable for the first time in Q2, and I expect much more will come soon.
Okta - Left for dead when they had a really tough calendar 2022, and hasn’t bounced back (yet) although the numbers have been good in 2023. If they can keep growth in the 20’s, I think there’s tons of upside. If they grow in the teens next year, it’s still a bargain as long as EPS keeps climbing. They just raised this year’s guide from 0.93 to 1.20 and there’s still time to raise again in Q3 and then beat that. And net margin is only about 10%, so I could see them greatly expanding EPS next year too.
Aehr Test Systems - They did $65m revenue last year and hope to best $100m this year. Nice ~30%ish profit margin. Things are looking promising for them this coming year and beyond, but man are they a tiny company.
Procore - Niche SaaS (construction), and I think they’re still a little underappreciated by the market. Like Samsara, expanding profits are imminent.
Nvidia - NVDA Q2 Earnings - #5 by PaulWBryant
Celsius - How long can this torrid growth last? I really don’t know, but there seems to be a big market for energy drinks, and they seem like the “it” brand right now, taking massive share.
Monday - I looked at BILL and CRWD and DDOG and ZS and I just think Monday is putting up better numbers right now, with no signs of stopping. They’ve gone from -16% FCF to +26% FCF margin in 4 quarters. That’s impressive. I don’t expect them to take over the world, but they appear to be executing really well.
Wrapping up:
The indexes actually ended August down a bit, so I’m thrilled with the way the portfolio performed. Axon did a lot of the heavy lifting, and just adding and trimming opportunistically helped a lot too.
Who knows what the rest of the year will bring? I’m optimistic as always, but I’m also aware that anything can happen. We have to enjoy the wins when we can get them, and August was a good one to me. I hope to you too.
I heard someone mention a thought experiment recently. What if you had to live your life over again? Maybe once…maybe more. But every time, you have to live it the exact same way you lived it this time!
The point of course: Live it this time in a way that would make that a treat and not a sisyphean struggle! That’s gonna be the thought I try to focus on and live out in September! May it be a kind month to us all!
Bear
“Compound interest is the eighth wonder of the world. He who understands it, earns it … he who doesn’t … pays it.” - Attributed to Albert Einstein
Previous Month Summaries
Dec 2016 (contains links to all 2016 monthly posts): Bear's Portfolio at the end of 2016 - Saul’s Investing Discussions - Motley Fool Community
Dec 2017 (contains links to all 2017 monthly posts): Bear's Portfolio through Dec 2017 - Saul’s Investing Discussions - Motley Fool Community
Dec 2018 (contains links to all 2018 monthly posts): Bear's Portfolio through Dec 2018 - Saul’s Investing Discussions - Motley Fool Community
Dec 2019 (contains links to all 2019 monthly posts): Bear's Portfolio through Dec 2019 - Saul’s Investing Discussions - Motley Fool Community
Dec 2020 (contains links to all 2020 monthly posts): Bear's Portfolio through Dec 2020 - Saul’s Investing Discussions - Motley Fool Community
Dec 2021 (contains links to all 2021 monthly posts): Bear's Portfolio through 12/2021 - Saul’s Investing Discussions - Motley Fool Community
Dec 2022 (contains links to all 2022 monthly posts): Bear's Portfolio through 12/2022
Jan 2023: Bear's Portfolio through 01/2023
Feb 2023: Bear's Portfolio through 02/2023
mid-Mar 2023: Bear's Mid-March Update
Mar 2023: Bear's Portfolio through 03/2023
Apr 2023: Bear's Portfolio through 04/2023
May 2023: Bear's Portfolio through 05/2023
June 2023: Bear's Portfolio through 06/2023
July 2023: Bear's Portfolio through 07/2023 (and Aug 3)